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ABSTRACT 
Chagas disease (CD) is still a neglected disease. Infected individuals are diagnosed late, 
being treated in worse clinical conditions. Thus, this study aimed to analyze the prevalence 
and the factors associated with new confirmed cases of CD identified by serological 
screening in an endemic region of Minas Gerais State, Brazil. This is an analytical cross-
sectional study with data from a project of the Research Center in Tropical Medicine of Sao 
Paulo- Minas Gerais (SaMi-Trop) conducted in two municipalities. Data collection included 
a questionnaire with closed questions, a venous blood collection and an ELISA serological 
test for CD. A total of 2,038 individuals with no previous diagnosis of CD participated in 
the study. The result of the serological test for CD was adopted as the dependent variable. 
The independent variables addressed personal issues, health conditions and lifetime 
housing. A descriptive analysis of individual variables was performed. Subsequently, a 
bivariate analysis was performed using the Pearson’s chi-square test. Households sheltering 
individuals positive for CD were georeferenced, and the analysis of spatial distribution 
was performed using the quartic function to estimate the density of the nucleus. Among 
the participants, 188 (9.2 %) were positive for CD. The profile of participants with CD 
was associated with place of residence, age, relative/family member with CD and living 
conditions. It is noteworthy that there are still patients with CD who are unaware of their 
diagnosis in both, rural and urban areas. 
KEYWORDS: Chagas disease. Serologic tests. Spatial analysis.
INTRODUCTION
Chagas disease (CD), caused by the protozoan Trypanosoma cruzi, is a neglected 
disease1. It still constitutes a major social and public health problem in endemic 
countries, and represents an emerging health problem in non-endemic countries2,3. 
In both places of occurrence, there is inexperience of health professionals4,5 and a 
high rate of underdiagnosis2,5-7.
It is estimated that 6 to 7 million people are infected worldwide8. In Brazil, 
it was estimated that between 1.3 and 3.2 million people would be infected with 
T. cruzi in 20202. However, the country does not have data on the prevalence of 
chronic CD. Although the notification of chronic cases of CD became mandatory 
in 20209, the CD control program is disjointed and its actions are discontinuous10.
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From 2009 to 2018, 45,863 deaths were recorded in 
Brazil as a result of CD11. Of these, 11,343 (24.7 %) were 
registered in the Brazilian Minas Gerais State, and the 
highest number of deaths, 2,300 or 20.2 %, were reported 
by the Northern health macro-region11. Although much of 
Northern Minas Gerais has been identified as an area of 
high risk for vector transmission of CD or of reestablished 
home transmission12, there is no investigation of CD in 
the prenatal care routine13 and many infected people are 
unaware of their condition14.
The late diagnosis of CD makes infected people arrive 
in worse clinical conditions to the health system, favoring 
the evolution of the disease, decreasing the quality of life of 
infected individuals, increasing their morbidity and mortality 
and causing a significant economic loss15-17. The absence 
of accessible diagnostic methods and the lack of specific 
information on CD by health professionals, leaves infected 
individuals unidentified, and therefore, untreated4,18. This 
reality mainly affects vulnerable populations13. An early 
diagnosis allows the access to an appropriate treatment, 
minimizing complications of the disease, and lowering the 
corresponding mortality2. In addition, it is recommended that 
the diagnosis be made in all suspected cases2.
Thus, this study aimed to analyze the prevalence and 
the factors associated with new confirmed cases of CD 
identified by serological screening in an endemic region 
of Minas Gerais State, Brazil.
MATERIALS AND METHODS
Ethical approval
This study was approved by the Ethics Committee of 
the State University of Montes Claros (CEP/UNIMONTES 
Nº 3.502.440/2018). All participants agreed to participate in 
this study and signed the Informed Consent Form.
Study design
This is a cross-sectional analytical study with data 
from a project performed at the Center for Research in 
Tropical Medicine of Sao Paulo-Minas Gerais (Centro de 
Pesquisa em Medicina Tropical de Sao Paulo-Minas Gerais 
- SaMi-Trop). This multicenter project is carried out by 
researchers from four Brazilian public universities in the 
States of Minas Gerais and Sao Paulo, Brazil. Its purpose 
is to develop and conduct research projects on CD.
Study area
This study was conducted in two municipalities 
in the Northern region of the Brazilian State of 
Minas Gerais: Espinosa (Latitude: 15°56’55” South; 
Longitude 44°51’52”  West) and Sao Francisco 
(Latitude:15°56’41” South; Longitude: 44°51’14” West). 
The territorial extension of Espinosa is 1,884.23 km2 and of 
Sao Francisco is 3,312.27 km². The population of Espinosa 
comprises 31,113 inhabitants and of Sao Francisco 53,82819. 
Both municipalities have high coverages of the Family 
Health Strategy (FHS) and more than 98% of the population 
depends on the Primary Health Care (PHC) offered by the 
Public Health System (Sistema Unico de Saude - SUS)20.
Sample
Individuals over the age of 18 and belonging to the 
FHS coverage area were invited. The sample was defined 
in a non-probabilistic way. The exclusion criterion was: 
individuals with a previous diagnosis of CD.
A total of 2,056 individuals participated in the stage of 
sample collection. However, for this study, 18 individuals 
who reported having been diagnosed with CD were 
excluded from the analysis, thus 2,038 were eligible.
Data collection
A meeting was held with the managers and nurses 
responsible for the FHS of the respective municipalities 
in order to inform them on the planned intervention and 
request their consent to carry out the study. After their 
acceptance, the municipalities made available an accessible 
FHS unit to carry out the data collection. Nurses passed 
on the information to the community health workers 
(CHW). Then, upon a scheduled date, the CHW invited 
the community to participate in the study and informed that 
more than one family member could participate.
The data collection took place between February 
and November 2019, and included a questionnaire with 
closed questions and one collection of venous blood. The 
questionnaire was applied to the participants with the 
questions addressing personal information, health and 
housing conditions during their lives. 
Serological screening
The collected venous blood samples were centrifuged 
the resulting serum was stored at -20 °C and subsequently 
sent in dry ice to the Institute of Tropical Medicine of 
the University of Sao Paulo (IMT-USP), where two 
enzyme linked immune sorbent assays (ELISA) tests were 
performed in duplicate, using commercial kits (Chagatest, 
Wiener Lab, Rosario, Argentina, and Trypanosoma cruzi 
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IgG, Euroimmun, Lübeck, Germany) according to the 
manufacturer’s instructions. To confirm the serological 
diagnosis, it was necessary to obtain concordant results in 
at least two serological tests of different methodological 
principles or antigenic preparations2.
Individuals identified with CD who authorized the 
notification of their condition, and those with inconclusive 
serology, were included in the flow of the Brazilian unified 
health system for the continuity of their health care and 
treatment of CD.
Variables
The results of the ELISA tests were adopted as the 
outcome (dependent variable), dichotomized into two 
categories (negative/inconclusive vs. positive). The 
independent variables were composed by city, age, gender, 
relative/family member with CD, knowledge on triatomine 
insects, have lived in an area with triatomine insects, have 
lived in a wooden/wattle and daub/adobe house. The age 
was calculated based on the date of birth of the participants 
and categorized as: up to 35 years, from 36 to 55 years, from 
56 to 75 and 76 years or more.
Statistical analysis
The descriptive analysis of individual variables was 
performed, estimating absolute (n) and relative (%) 
frequencies for the categorical variables and calculating 
the central tendency and dispersion measures for the 
numerical variables. Subsequently, a bivariate analysis was 
performed using the Pearson’s chi-square test, considering 
only the associations that maintained a significance level 
of up to 5 % (p < 0.05). The statistical software Statistical 
Package for the Social Sciences (SPSS) V.19 (SPSS Inc., 
IBM, Armonk, New York, USA) was used to carry out the 
analyzes conducted in this study.
The households that sheltered individuals serological 
positive for CD were georeferenced on site using a Global 
Positioning System (GPS) navigation device (Garmin 
Etrex®️ Garmin Ltd., Olathe, USA). In the Qgis 3.4®️ program 
(version 3.4 Madeira, QGIS Development Team), the spatial 
distribution analysis of the residences was carried out 
using the quartic function of the kernel density estimation 
(KDE)21, considering a bandwidth of 500 m. KDE is a 
non-parametric function that estimates probable occurrence 
values based on the density of upcoming events.
RESULTS
A total of 2,038 individuals participated in this study, of 
which 188 (9.2 %) were serologically positive, 48 (2.6%) 
were inconclusive and 1,850 (90.8 %) were negative for 
CD. The inconclusive tests were repeated when these 
individuals were entered into the SUS, but for logistical 
and ethical reasons, we did not have access to these results. 
Among the participants, the majority live in the city of 
Sao Francisco, are female (63.5%), have a mean age of 
48.18 years (± 15.43), with a minimum age of 18 and a 
maximum of 94 years. They reported to be related to people 
with CD (50.8%), not having been bitten by triatomine 
insects (60.3 %), having lived in an area with triatomine 
insects (87.1 %), and having lived in a wooden/wattle and 
daub/adobe house (72.2 %) (Table 1).
Among the individuals diagnosed with CD, the mean 
age was 56.19 (± 9.02) years with a minimum of 35 and 
a maximum of 86 years old. The majority of individuals 
with a diagnosis of CD lived in the city of Espinosa (12%), 
while the majority of respondents lived in the city of Sao 
Francisco. When analyzing the distribution of positive 
diagnoses in the cities studied (Figure 1, Table 2), it was 
observed that 75 % of positive cases live in the rural area of 
Espinosa and 55 % live in the urban area of Sao Francisco.
In the bivariate analysis, it was observed that the 
characteristics that were statistically associated with 
positive diagnoses were age, having a family member with 
CD, have been bitten by the triatomine insect, have lived in 
an area with triatomine insects, and have lived in a wooden/
wattle and daub/adobe house (Table 1).
The individual variables that were statistically associated 
with the outcome were age, being related to people with CD, 
having been bitten by the triatomine insect, having lived in 
an area with triatomine insects, and have lived in a wooden 
house/wattle and daub/adobe.
DISCUSSION
The present study observed that the number of positive 
cases screened by serology corroborates the number of 
positive cases estimated by the high-risk population of the 
Clinical Protocol and Therapeutic Guideline for Chagas 
Disease (PCDT)22. 
With the increase in migration and progressive changes 
in the rural economy, the epidemiological patterns of CD 
have been modified, with a transition from acute rural 
to chronic urban disease23. In Minas Gerais State, it was 
observed that between 2001 and 2006, 84 cases of acute 
CD were reported, with 58% of the cases of acute CD being 
registered in the urban area24, a significant data, since for 
decades CD was restricted to rural areas and was strongly 
marked by poverty2. However, our study shows that it is not 
possible to generalize the epidemiological patterns of CD, 
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as the municipality of Sao Francisco presented an urban 
pattern, but the municipality of Espinosa presented a rural 
pattern. CD is still recognized as a neglected disease, which 
mainly affects vulnerable populations in need of public 
policies that promote access to health care1.
Regarding the age, our study corroborates the results 
of others25,26 who observed a greater relationship between 
positive serology and older people, suggesting that the 
infection by T. cruzi has happened in the past. From the 
1950s to the mid-1990s, campaigns to prevent CD were 
intensified, and since then, vector transmission has suffered 
a significant decrease. As a consequence, it is possible that 
the positive individuals in the study became infected in a 
period prior to the campaigns to combat CD2,26,27. Another 
factor to consider would be the lack of adequate training 
of PHC professionals during their under graduation studies 
as well as their professional lives, leading to the failure to 
consider the suspicion of CD in their patients4, making the 
early diagnosis and treatment unfeasible. 
Having a relative/family member with CD was 
associated with a positive diagnosis. Other studies have 
also observed a history of CD in the families of diagnosed 
patients28,29. The authors hypothesized that these infections 
occurred through vector transmission, due to their region of 
birth, being in the rural area or in an endemic area, and the 
presence of triatomine insects in the households28,29. This 
demonstrates the relevance of medical care to the entire 
family group. In addition, another possibility of infection 
is through congenital transmission12. A systematic review 
with meta-analysis carried out in Brazil, in 2014, reported a 
congenital transmission rate ranging from 0 to 5.2%30. The 
WHO recommends that all pregnant women be subjected 
to serology to T. cruzi31, but this has not yet been achieved, 
and CD continues to be neglected and excluded from the 
prenatal care examinations13.
Having previous contact with the CD vector through a 
triatomine bite was associated with a positive diagnosis. 
In 2006, Brazil was certified for the interruption of the 
transmission of CD by its main vector, and also made 
progress in the transfusion screening32. Even in the face 
of these achievements, an alert is essential, as it is still 
possible to find residual foci in the Brazilian territory 













Espinosa 897 (44%) 789 (88%) 108 (12%) <0.001
Sao Francisco 1,141 (56%) 1,061 (93%) 80 (7%)
Age in years*
Up to 35 454 (22.1 %) 453 (99. 8 %) 1 (0.2 %) <0.001
36 to 55 884 (43.4 %) 795 (89.9%) 89 (10. 1%) 
56 to 75 614 (30. 1%) 523 (85.2%) 91 (14. 8%)
76 of or more 84 (4.1%) 77 (91.7%) 7 (8.3%)
Gender
Male 743 (36.5%) 664 (89.4%) 79 (10.6%) 0.096
Female 1,295 (63.5%) 1,186 (91.6%) 109 (8.4%)
Relative/family member with CD*
No 846 (49.2%) 793 (93.7%) 53 (6.3%) <0.001
Yes 875 (50.8%) 775 (88.6%) 100 (11.4%)
Triatomine insect*
No 786 (60.3%) 742 (94.4%) 44 (5.6%) <0.001
Yes 518 (39.7%) 444 (85.7%) 74 (14.3%)
Lived in an area with triatomine insects*
No 256 (12.9%) 248 (96.9%) 8 (3.1%) 0.001
Yes 1,732 (87.1%) 1,556 (89.8%) 176 (10.2%)
Lived in a wooden/wattle and 
daub/adobe house*
No 565 (27.8%) 549 (97.2%) 16 (2.8%) <0.001
Yes 1,469 (72.2%) 1,298 (88.4%) 171 (11.6%)
*Variation of n = 2,038 due to missing information.
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capable of reintroducing the main vector of CD32. Bearing 
in mind that the studied municipalities are currently 
located in areas at risk of transmission of CD due to the 
presence of the vector, we cannot rule out the possibility of 
vector transmission in the individuals participating in the 
study, therefore continuous epidemiological surveillance 
actions are necessary12. The CD control program is in the 
epidemiological surveillance phase, where the population 
has a fundamental role, but many people do not have 
knowledge on the management and identification of the 
vector, making this type of control vulnerable33,34. A study 
carried out in Diamantina (Minas Gerais State) demonstrated 
that the population’s knowledge on the identification of 
the CD vector is indispensable for the correct referral of 
insects to the control service. In areas where people had 
sufficient knowledge to identify the vector, entomological 
surveillance actions were more assiduous35. This indicates 
the need to carry out health education activities, because, 
through alerting and bringing knowledge, it is possible to 
achieve an effective control.
Living in a wooden, wattle and daub, or adobe house 
at some point in life was related to positive serology. 
Housing characteristics have already been reported to be 
significantly associated with domestic infestation of the 
CD vector36. Houses built with wood, wattle and daub, 
or adobe have refuges that are ideal shelters for vector 
infestation, thus making their residents a food source, 
increasing the chances of infection by T. cruzi36. Despite 
the Federal Government’s incentive aimed to improve the 
civil construction in endemic regions of Brazil37, it is still 
possible to find precarious households in rural communities 
in the country. Adequate housing infrastructure generates 
Table 2 - Description of the place of residence of the individuals participating in the study (n = 2,038).
Municipality
Individuals surveyed Individuals diagnosed with CD
Rural zone Urban zone Total Rural zone Urban zone Total
Espinosa 377 (42.03%) 520 (57.97%) 897 (44%) 81 (75%) 27 (25%) 108 (12%)
Sao Francisco 417 (36.55%) 724 (63.45%) 1141 (56%) 36 (45%) 44 (55%) 80 (7%)
Figure 1 - Spatial distribution of cases diagnosed with Chagas disease in 2019, in the municipalities of Espinosa and Sao Francisco, 
Minas Gerais State (n = 2,038).
Cruz et al.
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positive impacts on health in general, thus the improvement 
of households is an important factor for vector control, as 
a long-term strategy37.
In the development of this study, some limitations 
were observed, among them the cross-sectional design, 
which does not allow establishing causal relationships. 
IN addition, there is a limitation of temporality, as it is 
not possible to verify when these people were infected. 
However, this type of design allows to characterize the 
population and identify risk groups. One of the strengths of 
our study was the high detection rate of patients with CD 
who were unaware of their condition. The low visibility of 
these individuals in the society is notorious and our study 
shows the deficit in coping with CD along with the PHC, 
which is the closest health resource for the population. 
Although a PCDT for CD was instituted in 2018 by the 
Ministry of Health, there is still no specific line of care for 
chronic CD patients22. CD continues to be neglected even 
one hundred years after its discovery, demonstrating the 
importance of actively searching for new CD carriers in 
an endemic region.
CONCLUSION
The profile of participants with positive CD serology 
identified in this study is associated with place of residence, 
age, family and life conditions. Our study demonstrates that 
in both, rural and urban areas, there are still people with CD 
who are unaware of their diagnosis. CD remains a major 
challenge for the SUS, thus it is necessary that the PHC 
together with the epidemiological surveillance establish 
effective protocols for the screening and management of 
CD.
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